[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341772-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341772-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","targeting-polrmt-by-imt1-inhibits-colorectal-cancer-cell-growth","Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth","","The study evaluates IMT1, a novel specific inhibitor of mitochondrial RNA polymerase POLRMT, as a potential anti-colorectal cancer strategy. Single-cell RNA sequencing and tissue comparisons show POLRMT overexpression in colorectal cancer cells and local tumor tissues, with lower expression in normal colon epithelium. IMT1 suppresses colony formation, viability, proliferation, cell-cycle progression, and migration, while inducing apoptosis and cell death through mitochondrial dysfunction, depolarization, oxidative damage, and reduced ATP levels. Targeted POLRMT silencing reproduces IMT1 effects, whereas restoring POLRMT reverses them. IMT1 also blocks Akt-mTOR pathway activation and markedly inhibits xenograft growth and lung metastasis in nude mice.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/targeting-polrmt-by-imt1-inhibits-colorectal-cancer-cell-growth/341772/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/targeting-polrmt-by-imt1-inhibits-colorectal-cancer-cell-growth/341772.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of this study?","Question",{"text":63,"@type":64},"The study investigates whether IMT1, a specific inhibitor of mitochondrial RNA polymerase (POLRMT), can inhibit colorectal cancer cell growth and metastasis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What evidence shows POLRMT is involved in colorectal cancer?",{"text":68,"@type":64},"Single-cell RNA sequencing and analyses of patient tissues indicate POLRMT is overexpressed in colorectal cancer cells and local colorectal tumor tissues, compared with lower levels in colon epithelial cells.",{"name":70,"@type":61,"acceptedAnswer":71},"How does IMT1 exert its anti-cancer effects?",{"text":72,"@type":64},"IMT1 suppresses POLRMT activity, disrupts mitochondrial function, causes mitochondrial depolarization and oxidative damage, reduces ATP, hinders Akt-mTOR activation, and triggers apoptosis and cell death.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341772,1790172685,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nTargeting POLRMT by IMT1 inhibits colorectal cancer cell growth  \nHao Wang1,2,6, Yuxin Liu3,6, Xing-sheng Lu 4 ✉, Yongyou Wu1 ✉, Wen Gu5 ✉ and Guojian Yin3 ✉  \n© The Author(s) 2024  \n\n|  |  |  |\n| --- | --- | --- |\n|  | This study investigates the potential anti-colorectal cancer (CRC) activity of IMT1, a novel speciﬁc inhibitor of mitochondrial RNA polymerase (POLRMT) . Single-cell RNA sequencing data reveal that POLRMT is overexpressed in CRC cells. Additionally, elevated POLRMT expression was observed in local CRC tissues and cells, while its expression remained relatively low in colon epithelial tissues and cells. IMT1 signiﬁcantly inhibited colony formation, cell viability, proliferation, cell cycle progression, and migration in both primary and immortalized CRC cells. Furthermore, IMT1 induced apoptosis and cell death in CRC cells. The inhibition of POLRMT by IMT1 disrupted mitochondrial functions in CRC cells, leading to mitochondrial depolarization, oxidative damage, and decreased ATP levels. Using targeted shRNA to silence POLRMT closely mirrored the effects of IMT1, showing robust anti-CRC cell activity. Crucially, the efﬁcacy of IMT1 was diminished in CRC cells with silenced POLRMT. Contrarily, boosting POLRMT expression externally by a lentiviral construct promoted the proliferation and migration of CRC cells. Importantly, treatment with IMT1 or silencing POLRMT in primary colon cancer cells decreased the phosphorylation of Akt1-S6K1, whereas overexpression of POLRMT had the opposite effect. In nude mice, orally administering IMT1 potently restrained primary colon cancer xenograft growth. IMT1 suppressed POLRMT activity, disrupted mitochondrial function, hindered Akt-mTOR activation, and prompted apoptosis within the xenograft tissues. In addition, IMT1 administration suppressed lung metastasis of primary colon cancer cells in nude |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  | mice. These combined results highlight the robust anti-CRC activity of IMT1 by speciﬁcally targeting POLRMT. |  |\n|  |  |  |\n|  |  |  |\n|  | Cell Death and Disease (2024)15:643; [https://doi.org/10.1038/s41419-024-07023-8](https://doi.org/10.1038/s41419-024-07023-8) |  |\n|  |  |  |\n\nINTRODUCTION  \nColorectal cancer (CRC), a globally pervasive malignancy [1–3], exhibits a predilection for individuals aged 50 and older, displaying considerable regional variation in its incidence [1–3] . The etiology of CRC is multifactorial, implicating lifestyle variables including dietary habits, sedentary behavior, familial history, and the presence of inﬂammatory bowel disease (IBD) [4, 5] . Robust evidence underscores the utility of systematic screening initiatives, designed for the early identiﬁcation of CRC, in mitigating its incidence and associated mortality, particularly in select nations [1–3] . In light of its persistent prominence as a leading cause of cancer-related mortalities [1–3], the imperative for preventative measures, timely interventions, and molecularly targeted therapeutic for CRC assume paramount signiﬁcance [4, 5] .  \nMitochondria serve as central orchestrators of cellular energy metabolism through oxidative phosphorylation (OXPHOS) in CRC [6, 7] . The malignancy of CRC is underscored by notable perturbations in mitochondrial homeostasis, encompassing variations in mitochondrial DNA (mtDNA) content, the emergence of mtDNA mutations, and disruptions in the expression of pivotal mitochondrial genes [8–10] . These aberrations exert substantial inﬂuence on the progression of CRC, impacting critical cellular  \nprocesses, including energy metabolism, cell proliferation, andapoptotic mechanisms [8–12] .  \nRNA polymerase mitochondrial (POLRMT) serves as a crucial enzyme responsible for transcribing mtDNA in eukaryotic cells [13–16] . POLRMT is located in mitochondria and assu","cbCaihF8cocgfJRj","https://ap.wps.com/l/cbCaihF8cocgfJRj","pdf",7456083,15,"English","# Introduction\n## Background on colorectal cancer\n## Mitochondrial dysfunction and POLRMT in cancer\n## Prior evidence linking POLRMT to tumor progression","[{\"question\":\"What is the main focus of this study?\",\"answer\":\"The study investigates whether IMT1, a specific inhibitor of mitochondrial RNA polymerase (POLRMT), can inhibit colorectal cancer cell growth and metastasis.\"},{\"question\":\"What evidence shows POLRMT is involved in colorectal cancer?\",\"answer\":\"Single-cell RNA sequencing and analyses of patient tissues indicate POLRMT is overexpressed in colorectal cancer cells and local colorectal tumor tissues, compared with lower levels in colon epithelial cells.\"},{\"question\":\"How does IMT1 exert its anti-cancer effects?\",\"answer\":\"IMT1 suppresses POLRMT activity, disrupts mitochondrial function, causes mitochondrial depolarization and oxidative damage, reduces ATP, hinders Akt-mTOR activation, and triggers apoptosis and cell death.\"}]","Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth | PDF",1790043728,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e387b4a28431e21559c9ecabe119da4.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbafe6b230f01809b613f8be074383af.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/062d847f42919e43697b5e5039935eca.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af86a279aaa6375790222fa99876eb93.webp",980,1301]